Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OTC Oxytrol Approval In U.S. Highlights European Switch Struggles

Apr 24 2013

• By Dan Schiff

Related Content

Pfizer Pulls Back On European Viagra Switch As Questions Linger

Nov 24 2008

Merck’s <em>Oxytrol</em> Could Be OTC Trailblazer For Chronic Conditions

Mar 11 2013

European Countries Urged To Boost OTC Profile In Health Care Systems

Jul 16 2012

Switch Environment Makes U.K. A Sound Warm-up For Centralized Switch

Sep 28 2009

Boehringer Launches Switched Flomax Relief MR For BPH In U.K.

Apr 05 2010

Related Companies

Johnson & Johnson

Merck & Co., Inc.

Boehringer Ingelheim GmbH

GSK plc

Novartis AG

Pfizer Inc.

Additional Topics

United States Austria Europe Belgium Czech Republic Denmark Finland France Germany Greece Ireland Italy Poland Norway Netherlands Portugal Slovenia Spain Sweden Switzerland Turkey United Kingdom Business Strategies Advertising, Marketing & Sales Distribution Manufacturing Prescription To OTC Switch Drug Approval Standards Regulation Compliance OTC Drugs Consumer BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window